Choice of First-Line Therapy in Follicular Lymphoma Debated

April 26, 2013

After years of debate over when to start treatment for follicular non-Hodgkin's lymphoma and when to "watch and wait," most experts now agree that patients with advanced disease who are symptomatic should be treated.

However, what therapy to use in the first instance remains "a conundrum," write Oliver Press, MD, PhD, from the Fred Hutchinson Cancer Research Center, and Maria Corinna Palanca-Wessels, MD, PhD, from the University of Washington, both in Seattle, in an editorial published in the April 20 issue of the Journal of Clinical Oncology.